29/10/2018 - 16:08

PharmAust maps out GMP drug production process

29/10/2018 - 16:08

Bookmark

Save articles for future reference.

PharmAust has developed a prototype “good manufacturing practice” method for the large-scale manufacture of its anti-cancer drug, Monepantel and its analogues at an economical cost and to standards required for clinical trials. The method can also be used for molecules in the drug library that PharmAust secured from Nihon Nohyaku in September 2017, which are related to but different from Monepantel.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options